What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
adverse drug reactions directly to the BASG. Physicians, pharmacists and other health care professionals are legally obliged to report adverse reactions. https://www.basg.gv.at/en/market-surveillance/repor [...] shortly afterwards ("background incidence"). In Austria, the Federal Office for Safety in Health Care (BASG) records all suspected adverse reactions to medicinal products and vaccines that have occurred in
Legal ordinances of BASG BASG on electronic transmission of applications and notifications (German only) Ordinance of the BASG on the electronic transmission of applications and notifications (Electronic [...] medical devices (German only) Ordinance of the BASG on fees for medical devices, version 30.07.2022 | 75 KB 01/08/2022 BASG on official badge (German only) BASG communication on official badges, version 30 [...] Ordinance of the BASG on the electronic transmission of applications and notifications (Electronic Ordinance on Submissions 2011 - EEVO 2011) version 30.07.2022 | 58 KB 01/08/2022 Ordinance of the BASG on the
BASG publications After the decision has been made, the results of the BASG votes and the issued notices of the BASG are entered in the list in an electronic release process. BASG announcements listed [...] listed on a daily basis. From the foundation of the BASG on 01.01.2006 to 19.06.2013, voting took place by circulation. The agendas, votes and announcements from this period can be found in the subordinate pages [...] pages. The Rules of Procedure of the BASG applies to the procedure of the Federal Office for Safety in Health Care as amended. The Annex to the Rules of Procedure establishes the authorisation to issue
BASG announcements Since 01.08.2013 BASG authorisations and changes of medicinal products related to the identification are listed on a daily basis under BASG-Verlautbarung. Since 25.06.2015 centrally
BASG approval procedure Since 2013: After the decision has been made, the results of the BASG votes are listed in an electronic release process updated daily. Voting archive 2012-2013 BASG Abstimmungen
in Health Care (BASG) AGES Austrian Medicines and Medical Devices Agency Traisengasse 5 A-1200 Vienna Tel. national: 050 555-36111 Tel. international: +43 (0)50 555-36111 E-Mail: basg@basg.gv.at Responsible: [...] MDRA (Member of the BASG responsible for the procedure and Head of the AGES Austrian Medicines and Medical Devices Agency) Internet editorial office: E-mail: redaktion-basg@basg.gv.at Disclosure pursuant [...] the website, please contact redaktion-basg@basg.gv.at . Disclaimer Here you can find our privacy policy . Editorial content management, conception & specification: BASG / AGES Austrian Medicines and Medical
ges.at Enquiries (for media): Communications Management, Tel.: +43 505 55-25000 E-mail: presse-basg@basg.gv.at [...] reactions during #MedSafetyWeek: November 6-12, 2023. The Federal Office for Safety in Health Care (BASG) is taking part in the global social media campaign called #MedSafetyWeek to raise public awareness [...] therefore make a significant contribution to ensuring that medicines are safer for everyone and that the BASG (Federal Office for Safety in Health Care) can protect public health even better through effective
note Notification veterinary medicinal products basg-v-phv@basg.gv.at Notification blood and tissue products haemovigilanz@basg.gv.at gewebevigilanz@basg.gv.at [...] electronic notification form veterinary paper form for doctors paper form by e-mail to: basg-v-phv@basg.gv.at by mail to: BASG, 1200 Vienna, Traisengasse 5 Reporting options for blood and tissue products paper [...] e-mail to: haemovigilanz@basg.gv.at gewebevigilanz@basg.gv.at Notification forms (available in German only) Nebenwirkung Arztmeldung Veterinär (F_Z70) | 197 KB 24/07/2018 BASG Meldung unerwünschter Ereignisse
ns. The report is made to the BASG or to the pharmaceutical company who is the marketing authorization holder or distributor of the medicinal product concerned. The BASG accepts the notifications online